FDA Inspection
Oleksandra Stasyshyn, MD, PhDOleksandra Stasyshyn, MD, PhD – FDA Inspection, Jan 25, 2013
Record Details
This FDA Inspection record concerns Oleksandra Stasyshyn, MD, PhD, with an inspection on January 25, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 25, 2013
- Product Type
- Biologics
View Company Profile
ID · 3fdc6df3-9a49-4514-a723-12dfa0c925f7
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 816247
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Oleksandra Stasyshyn, MD, PhD
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 1, 2016 | NAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Oleksandra Stasyshyn, MD, PhD
- FDA Inspection 980891 - 2016-07-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.